Results 61 to 70 of about 6,528 (217)

Long‐Term Outcomes of Surgical Management for Submandibular Sialolithiasis: Gland Resection Versus Preservation

open access: yesLaryngoscope Investigative Otolaryngology, Volume 11, Issue 4, August 2026.
ABSTRACT Objective Describe long‐term outcomes of submandibular sialolithiasis treatment, comparing gland‐preserving procedures to gland resection. Methods This retrospective cohort study with prospective patient‐reported outcome assessment study included all patients who underwent initial surgical management of submandibular sialolithiasis by a single
Claire Orth   +5 more
wiley   +1 more source

Diagnostic Use of Testing for Novel Murine Autoantibodies for Sjögren Disease in the Rheumatology Outpatient Setting

open access: yesArthritis Care &Research, Volume 78, Issue 7, Page 875-882, July 2026.
Objective The goal was to assess the diagnostic performance of three novel autoantibodies (NA) for Sjögren disease (SjD) by comparing NA prevalence in patients with SjD, other autoimmune rheumatic diseases (ARDs), nonspecific chronic sialadenitis (CS), and controls.
Chadwick R. Johr   +5 more
wiley   +1 more source

Clinical case of an acute nonspecific parotitis at a newborn [PDF]

open access: yesСаратовский научно-медицинский журнал, 2016
This article presents a rare case of isolated parotid sialadenitis at a newborn. Possible etiology, classification, frequency, diagnosis and management of the disease are described in orderto determine this pathology.
Bochkova L.G., Mikhryacheva V.V.
doaj  

Sjögren Disease—B Cells at the Brink: From Autoimmunity to Lymphomagenesis and the Rise of Novel B Cell–Targeted Therapies

open access: yesArthritis &Rheumatology, Volume 78, Issue 7, Page 1393-1402, July 2026.
Sjögren disease (SjD) is a common systemic autoimmune disorder characterized by inflammation of the exocrine glands, resulting in dryness. Patients frequently exhibit extraglandular manifestations affecting various organ systems. To date, there are no US Food and Drug Administration (FDA)‐approved disease‐modifying therapies for SjD. In this review, we
Rachael A. Gordon, Sara S. McCoy
wiley   +1 more source

Impact of Steroid Pulse Therapy on Early Treatment Response and Relapse in Type 1 Autoimmune Pancreatitis

open access: yesJGH Open, Volume 10, Issue 7, July 2026.
ABSTRACT Aims Despite the recommendation of steroid therapy for type 1 autoimmune pancreatitis (AIP), the value of steroid pulse therapy remains unclear. This study aimed to assess the efficacy and safety of steroid pulse therapy in patients with AIP. Methods and Results Of 121 patients with type 1 AIP who were identified, 116 with adequate follow‐up ...
Akihisa Adachi   +11 more
wiley   +1 more source

Chronic Sclerosing Sialadenitis in the Minor Salivary Glands: A Case Report

open access: yesMajallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Shahīd Ṣadūqī Yazd, 2012
Chronic sclerosing sialadenitis(also known as Kuttner tumor) is a chronic inflammatory condition of the salivary glands and one of the salivary gland enlargment that was first described by Kuttner in 1896.
N Gholami, N Boostani, O mahdavi
doaj  

IgG4-related chronic sclerosing sialadenitis in a child with recurrent parotitis: a case report

open access: yesBMC Pediatrics, 2021
Background IgG4-related disease (IgG4-RD) includes a group of immune-mediated diseases histologically characterized by lymphoplasmacytic infiltrate with a prevalence of IgG4-positive plasma cells, storiform fibrosis and obliterative phlebitis. Autoimmune
Fabio Timeus   +4 more
doaj   +1 more source

Decreased Serum Vitamin D Is Not Associated With Sjögren Disease in European and Asian Subjects

open access: yesACR Open Rheumatology, Volume 8, Issue 5, May 2026.
Objective To identify whether serum vitamin D [25(OH)D] and vitamin D receptor‐binding variants (VDR‐BVs) previously implicated in multiple sclerosis (MS) are associated with Sjögren disease (SjD) susceptibility and related clinical outcomes, with the overall goal of understanding the relationship between vitamin D and SjD pathogenesis.
Defne S. Yilmaz   +4 more
wiley   +1 more source

A Case of Anti‐AMY1‐Positive Lung Squamous Cell Carcinoma With Severe Hyperamylasemia Linked to Disease Progression

open access: yesRespirology Case Reports, Volume 14, Issue 5, May 2026.
We present a case of anti‐AMY1‐positive lung squamous cell carcinoma (LUSC) with severe hyperamylasemia. To our knowledge, no previous cases of LUSC have been reported with both histological evidence of amylase production and hyperamylasemia. This case provides new evidence that LUSC can produce amylase and cause hyperamylasemia. ABSTRACT A 74‐year‐old
Yusuke Nakamura   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy